Sign in

CIK 0001824893

  • Non-accelerated filer
  • Smaller reporting company

Surrozen, Inc./DE

Sign in to watch
Ticker
SRZN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
301374889
Phone
+1 650-475-2820
Business address
171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Consonance-HFW Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-10-10 Parker Craig C Chief Executive Officer Grant or award · Option (right to buy) +181,270 181,270
2022-10-10 Parker Craig C Chief Executive Officer Grant or award · Option (right to buy) +2,065 2,065
2022-07-01 Yeh Wen-Chen Chief Scientific Officer Grant or award · Option (right to buy) +500 500
2022-06-07 Kutzkey Tim Director Grant or award · Option (right to buy) +20,000 20,000
2022-06-07 CHAI CHRISTOPHER Y Director Grant or award · Option (right to buy) +20,000 20,000
2022-06-07 Haak-Frendscho Mary Director Grant or award · Option (right to buy) +20,000 20,000
2022-06-07 WOODHOUSE DAVID J Director Grant or award · Option (right to buy) +20,000 20,000
2022-06-07 Rothenberg Mace Director Grant or award · Option (right to buy) +20,000 20,000
2022-06-07 Lin Shao-Lee Director Grant or award · Option (right to buy) +20,000 20,000
2022-06-07 Berkenblit Anna Director Grant or award · Option (right to buy) +20,000 20,000
2022-03-01 Yeh Wen-Chen Chief Scientific Officer Grant or award · Option (right to buy) +125,000 125,000
2022-03-01 Parker Craig C Chief Executive Officer Grant or award · Stock Option (right to buy) +370,000 370,000
2022-03-01 Williams Charles O Chief Financial Officer Grant or award · Option (right to buy) +125,000 125,000
2022-03-01 Vanhove Geertrui Chief Medical Officer Grant or award · Option Grant (right to buy) +125,000 $3.11 $389K 125,000
2021-08-12 Parker Craig C Chief Executive Officer Grant or award · Stock Option (right to buy) +183,335 183,335
2021-08-12 Vanhove Geertrui Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +36,647 36,647
2021-08-12 Williams Charles O Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +14,597 14,597
2021-08-11 Consonance Life Sciences Former 10% Holder Returned to the company −434,000 0
2021-08-11 Consonance Life Sciences Former 10% Holder Other disposition −759,000 1,451,000
2021-08-11 Consonance Life Sciences Former 10% Holder Returned to the company −1,451,000 0

Page 15 of 20 · 398 trades